Skip to content
Accretion Nutraveda logo

Accretion Nutraveda IPO

Check allotment status
Issue price
₹129
Listing price
₹191
+48.06%
Current price
₹348.8
+170.39%
Subscribed
1.77x
Issue size
—
Listed on
4 Feb 2026

IPO timeline

  1. Opens
    28 JanWed
  2. Closes
    30 JanFri
  3. Allotment
    2 FebMon
  4. Refunds
    3 FebTue
  5. Demat credit
    3 FebTue
  6. Listing
    4 FebWed

Issue details

Price band
₹122 – ₹129 per share
Issue size
—
Fresh issue
Not available
Offer for sale
Not available
Issue type
Fresh capital only
Face value
₹10 per share
Lot size
1,000 shares
Minimum investment
₹1,29,000
Listing on
BSE SME
Exchange code
ANL.BO · 7564

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)11,000₹1,29,000
Retail (Max)11,000₹1,29,000
HNI (Min)22,000₹2,58,000

Reservation

QIB
9,08,000 shares (49.78% of the Offer)
NII
2,76,000 shares (15.13% of the Offer)
Retail
6,40,000 shares (35.09% of the Offer)

Allotment status

Registrar: KFin Technologies Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on KFin Technologies
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
2 Feb 2026
Refunds initiated
3 Feb 2026
Shares credited to demat
3 Feb 2026
Listing
4 Feb 2026

Grey market premium (GMP)

Updated 04 Feb 2026, 10:37 AM IST
Current GMP
₹65
+50.00%
Estimated listing price
₹194
Issue price ₹129
Highest
₹65
4 Feb
Lowest
₹0
27 Jan

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
4 Feb 2026₹65+50.00%₹194
3 Feb 2026₹17+13.00%₹146
2 Feb 2026₹6+5.00%₹135
1 Feb 2026₹6+5.00%₹135
31 Jan 2026₹6+5.00%₹135
30 Jan 2026₹0—₹129
29 Jan 2026₹0—₹129
28 Jan 2026₹0—₹129
27 Jan 2026₹0—₹129
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 26 Feb 2026, 04:18 AM IST
Overall subscription
1.77x
Fully subscribed
  • QIB1.01x
  • NII (HNI)1.8x
  • Retail2.19x
CategoryShares offeredShares bid forSubscribed
Qualified Institutional Buyers (QIB)3,64,0003,67,0001.01x
Non-Institutional Investors (NII)3,72,0006,69,0001.8x
Retail Individual Investors (RII)6,40,00014,04,0002.19x
Total13,76,00024,40,0001.77x

Financials

Amounts in Rs. Crore
P/E Ratio
20.02
EPS (₹)
6.44
RoCE
36.98%
RoNW
48.85%
PAT Margin
16.33%

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets16.3510.864.644.06
Total Income14.0716.065.203.07
Profit After Tax2.332.610.820.28
EBITDA3.293.651.210.59
NET Worth8.265.351.080.26
Reserves and Surplus2.954.860.72-0.10
Total Borrowing4.433.862.171.97
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Accretion Nutraveda
This IPO
—20.0248.85%16.33%1.77x+48.06%
Hannah Joseph Hospital
SME · listed 1 Feb 2026
—15.5214.74%9.30%1.51x-7.14%
KRM Ayurveda
SME · listed 27 Jan 2026
—23.7367.86%15.80%74.43x+27.48%
Modern Diagnostic & Research Centre
SME · listed 7 Jan 2026
—11.3343.27%11.51%350.49x0.00%
Goldline Pharmaceutical
SME · listed 19 May 2026
₹12 Cr13.9327.37%10.09%781.85x+38.95%
Himalaya Nutravedics India
SME · listed 29 Sep 2026
₹26.5 Cr12.6345.12%17.16%2.24x+11.32%
Speciality Medicines
SME · listed 30 Mar 2026
₹29 Cr10.4928.30%14.77%2.19x0.00%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹27.46 Cr total

How Accretion Nutraveda plans to use the money raised, as stated in the offer document.

  1. Capital expenditure towards purchase of new equipment/ machineries, etc. ₹2.7 Cr
  2. Capital expenditure towards upgradation of existing manufacturing facility ₹4.66 Cr
  3. Repayment/prepayme nt of certain borrowings availed by the Company ₹0.99 Cr
  4. Funding working capital requirements₹14.68 Cr
  5. General Corporate Purpose₹4.43 Cr

About Accretion Nutraveda

Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels. The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women’s health, bone and joint health, cognitive support, and respiratory wellness.

Promoters and shareholding

Ankurkumar Shantilal Patel, Hardik Mukundbhai Prajapati, Harshad Nanubhai Rathod, Mayur Popatlal Sojitra, Paraskumar Vinubhai Parmar and Vivek Ashok Kumar Patel

Promoter holding, pre-issue
100%
Promoter holding, post-issue
73.48%

Registrar, lead managers and documents

Registrar

KFin Technologies Limited

040-79615565

apl.ipo@kfintech.com

Company contact

27 Xcelon Industrial Park-1, Vasna-Chacharwadi, TaSanand, Ahmedabad, Gujarat, 382213

+91- 9904366177

compliance@accretionnutraveda.com

Accretion Nutraveda IPO: common questions

1.When does the Accretion Nutraveda IPO open and close?

The Accretion Nutraveda IPO opens on 28 Jan 2026 and closes on 30 Jan 2026.

2.What is the price band of the Accretion Nutraveda IPO?

The price band is ₹122 – ₹129 per share, with a lot size of 1,000 shares and a minimum investment of ₹1,29,000.

3.What is the GMP of the Accretion Nutraveda IPO?

The last reported grey market premium is ₹65 per share as of 04 Feb 2026, 10:37 AM IST. GMP is unofficial and changes frequently.

4.When is the Accretion Nutraveda IPO allotment?

The basis of allotment is expected on 2 Feb 2026. Allotment status can be checked with the registrar, KFin Technologies Limited.

5.When will the Accretion Nutraveda IPO list?

The shares listed on 4 Feb 2026 on BSE SME.

6.Who is the lead manager of the Accretion Nutraveda IPO?

The book running lead manager is Sobhagya Capital Options Pvt.Ltd., and the registrar is KFin Technologies Limited.

7.What will the money raised in the Accretion Nutraveda IPO be used for?

As stated in the offer document, the proceeds are for: Capital expenditure towards purchase of new equipment/ machineries, etc. ; Capital expenditure towards upgradation of existing manufacturing facility ; Repayment/prepayme nt of certain borrowings availed by the Company ; Funding working capital requirements; General Corporate Purpose.

8.How can my company launch an IPO like Accretion Nutraveda?

Start with an IPO readiness assessment: eligibility for the NSE Emerge or BSE SME platform, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393